Related Experiment Video

Updated: May 29, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?

Renata Costa1, Robert Wesolowski, Derek Raghavan

  • 1Cleveland Clinic Taussig Cancer Institute, Ohio State University James Cancer Institute, Columbus, USA.

BJU International
|September 3, 2011
PubMed

Insights

Advanced adrenal carcinoma is a difficult-to-treat cancer. New targeted therapies focusing on WNT/beta-catenin, EGFR, RAF, and k-RAS show promise for improving outcomes in this rare and aggressive disease.

Area of Science:

  • Oncology
  • Translational Medicine

Background:

  • Advanced adrenal carcinoma presents a significant therapeutic challenge with limited efficacy of conventional systemic therapies.
  • Current treatments yield low response rates (15-30%) and poor survival (median 6-15 months, <10% 5-year survival).

Purpose of the Study:

  • To review potential novel therapeutic targets for advanced adrenal carcinoma based on preclinical and pathological findings.
  • To highlight the need for structured clinical investigation of these targets.

Main Methods:

  • Review of preclinical and pathological studies identifying molecular targets in adrenal carcinoma.
  • Comparison with successful targeted therapies in similar cancers like melanoma and renal carcinoma.

Main Results:

  • Potential drug targets identified include WNT/beta-catenin, epidermal growth factor receptor (EGFR), RAF, and k-RAS.
  • These targets have shown success in treating other malignancies, suggesting potential efficacy in adrenal carcinoma.

Conclusions:

  • Advanced adrenal carcinoma is an orphan disease with high mortality, necessitating new treatment strategies.
  • Targeted therapies offer a promising avenue for improving patient outcomes and warrant further clinical trial investment.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...